<DOC>
	<DOCNO>NCT02074358</DOCNO>
	<brief_summary>The purpose study assess effect two 4-Factor PCC formulation Apixaban pharmacodynamics healthy adult subject .</brief_summary>
	<brief_title>A Study Assess Effects 2 Prothrombin Complex Concentrates Pharmacodynamics Apixaban Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Healthy subject Body Mass Index ( BMI ) 18 30 kg/m2 Ages 18 45 year , include Women childbearing potential ( WOCBP ) acceptable contraception negative pregnancy test breastfeed History evidence coagulopathy History evidence thrombosis deep vein thrombosis thromboembolic disease first degree relative 50 year age history thromboembolic disease Any significant acute chronic medical illness relevant trauma Any major surgery within 4 week dose ( prior dosing ) plan within 2 week completion study History heavy menstrual bleeding produce anemia within past 1 year Current symptomatic recent gastrointestinal disease surgery could impact absorption study drug History smoking within 1 month prior dose Recent history ( within 6 month dose ) pregnancy Use hormonal contraceptive Exposure investigational drug placebo within 4 week study drug administration Use agent , include limited Aspirin , Nonsteroidal antiinflammatory drug ( NSAIDs ) , Anticoagulants , Fish oil capsule , Gingko , etc , know increase potential bleeding , within 2 week prior dose History severe drug allergy include allergy Heparin history Heparininduced thrombocytopenia , hypersensitivity PCCs Factor Xa inhibitor , history allergy human blood plasma derive product ; history adverse drug reaction Anticoagulants Antiplatelet agent result excessive bleeding require medical intervention</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>